192 related articles for article (PubMed ID: 34579070)
21. Human Milk Oligosaccharides and Synthetic Galactosyloligosaccharides Contain 3'-, 4-, and 6'-Galactosyllactose and Attenuate Inflammation in Human T84, NCM-460, and H4 Cells and Intestinal Tissue Ex Vivo.
Newburg DS; Ko JS; Leone S; Nanthakumar NN
J Nutr; 2016 Feb; 146(2):358-67. PubMed ID: 26701795
[TBL] [Abstract][Full Text] [Related]
22. Effect of deoxynivalenol on the porcine acquired immune response and potential remediation by a novel modified HSCAS adsorbent.
Zhang L; Ma R; Zhu MX; Zhang NY; Liu XL; Wang YW; Qin T; Zheng LY; Liu Q; Zhang WP; Karrow NA; Sun LH
Food Chem Toxicol; 2020 Apr; 138():111187. PubMed ID: 32061728
[TBL] [Abstract][Full Text] [Related]
23. Specific prebiotic oligosaccharides modulate the early phase of a murine vaccination response.
Vos AP; Knol J; Stahl B; M'rabet L; Garssen J
Int Immunopharmacol; 2010 May; 10(5):619-25. PubMed ID: 20206301
[TBL] [Abstract][Full Text] [Related]
24. Characterizing microbiota-independent effects of oligosaccharides on intestinal epithelial cells: insight into the role of structure and size : Structure-activity relationships of non-digestible oligosaccharides.
Akbari P; Fink-Gremmels J; Willems RHAM; Difilippo E; Schols HA; Schoterman MHC; Garssen J; Braber S
Eur J Nutr; 2017 Aug; 56(5):1919-1930. PubMed ID: 27295033
[TBL] [Abstract][Full Text] [Related]
25. Deoxynivalenol photocatalytic detoxification products alleviate intestinal barrier damage and gut flora disorder in BLAB/c mice.
Zhou Y; Qi S; Meng X; Lin X; Duan N; Zhang Y; Yuan W; Wu S; Wang Z
Food Chem Toxicol; 2021 Oct; 156():112510. PubMed ID: 34390814
[TBL] [Abstract][Full Text] [Related]
26. Ingestion of deoxynivalenol (DON) contaminated feed alters the pig vaccinal immune responses.
Pinton P; Accensi F; Beauchamp E; Cossalter AM; Callu P; Grosjean F; Oswald IP
Toxicol Lett; 2008 Apr; 177(3):215-22. PubMed ID: 18329193
[TBL] [Abstract][Full Text] [Related]
27. Exposure to the mycotoxin deoxynivalenol reduces the transport of conjugated bile acids by intestinal Caco-2 cells.
Wang J; Bakker W; Zheng W; de Haan L; Rietjens IMCM; Bouwmeester H
Arch Toxicol; 2022 May; 96(5):1473-1482. PubMed ID: 35224661
[TBL] [Abstract][Full Text] [Related]
28. The impact of the Fusarium mycotoxin deoxynivalenol on the health and performance of broiler chickens.
Awad WA; Hess M; Twarużek M; Grajewski J; Kosicki R; Böhm J; Zentek J
Int J Mol Sci; 2011; 12(11):7996-8012. PubMed ID: 22174646
[TBL] [Abstract][Full Text] [Related]
29. Intestinal toxicity of the masked mycotoxin deoxynivalenol-3-β-D-glucoside.
Pierron A; Mimoun S; Murate LS; Loiseau N; Lippi Y; Bracarense AP; Liaubet L; Schatzmayr G; Berthiller F; Moll WD; Oswald IP
Arch Toxicol; 2016 Aug; 90(8):2037-46. PubMed ID: 26404761
[TBL] [Abstract][Full Text] [Related]
30. Chronic ingestion of deoxynivalenol at human dietary levels impairs intestinal homeostasis and gut microbiota in mice.
Vignal C; Djouina M; Pichavant M; Caboche S; Waxin C; Beury D; Hot D; Gower-Rousseau C; Body-Malapel M
Arch Toxicol; 2018 Jul; 92(7):2327-2338. PubMed ID: 29804187
[TBL] [Abstract][Full Text] [Related]
31. The Food-Associated Ribotoxin Deoxynivalenol Modulates Inducible NO Synthase in Human Intestinal Cell Model.
Graziani F; Pujol A; Nicoletti C; Pinton P; Armand L; Di Pasquale E; Oswald IP; Perrier J; Maresca M
Toxicol Sci; 2015 Jun; 145(2):372-82. PubMed ID: 25766886
[TBL] [Abstract][Full Text] [Related]
32. Agaro-oligosaccharides mitigate deoxynivalenol-induced intestinal inflammation by regulating gut microbiota and enhancing intestinal barrier function in mice.
Wang Q; Wang Y; Wang Y; Zhang Q; Mi J; Ma Q; Li T; Huang S
Food Funct; 2024 Apr; 15(7):3380-3394. PubMed ID: 38498054
[TBL] [Abstract][Full Text] [Related]
33. Prebiotic oligosaccharides in early life alter gut microbiome development in male mice while supporting influenza vaccination responses.
van den Elsen LWJ; Tims S; Jones AM; Stewart A; Stahl B; Garssen J; Knol J; Forbes-Blom EE; Van't Land B
Benef Microbes; 2019 Apr; 10(3):279-291. PubMed ID: 30773928
[TBL] [Abstract][Full Text] [Related]
34. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression.
Pinton P; Nougayrède JP; Del Rio JC; Moreno C; Marin DE; Ferrier L; Bracarense AP; Kolf-Clauw M; Oswald IP
Toxicol Appl Pharmacol; 2009 May; 237(1):41-8. PubMed ID: 19289138
[TBL] [Abstract][Full Text] [Related]
35. Deoxynivalenol exposure during pregnancy has adverse effects on placental structure and immunity in mice model.
Toutounchi NS; Braber S; Land BV; Thijssen S; Garssen J; Folkerts G; Hogenkamp A
Reprod Toxicol; 2022 Sep; 112():109-118. PubMed ID: 35840118
[TBL] [Abstract][Full Text] [Related]
36. Human Milk Oligosaccharides Attenuate Antigen-Antibody Complex Induced Chemokine Release from Human Intestinal Epithelial Cell Lines.
Zehra S; Khambati I; Vierhout M; Mian MF; Buck R; Forsythe P
J Food Sci; 2018 Feb; 83(2):499-508. PubMed ID: 29377120
[TBL] [Abstract][Full Text] [Related]
37. Mycotoxin detoxifiers attenuate deoxynivalenol-induced pro-inflammatory barrier insult in porcine enterocytes as an in vitro evaluation model of feed mycotoxin reduction.
Park SH; Kim J; Kim D; Moon Y
Toxicol In Vitro; 2017 Feb; 38():108-116. PubMed ID: 27737795
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling in spleens of deoxynivalenol-exposed mice: immediate early genes as primary targets.
Kinser S; Jia Q; Li M; Laughter A; Cornwell P; Corton JC; Pestka J
J Toxicol Environ Health A; 2004 Sep; 67(18):1423-41. PubMed ID: 15371230
[TBL] [Abstract][Full Text] [Related]
39. Deoxynivalenol as a contaminant of broiler feed: intestinal development, absorptive functionality, and metabolism of the mycotoxin.
Yunus AW; Blajet-Kosicka A; Kosicki R; Khan MZ; Rehman H; Böhm J
Poult Sci; 2012 Apr; 91(4):852-61. PubMed ID: 22399724
[TBL] [Abstract][Full Text] [Related]
40. Effects of feed contaminant deoxynivalenol on plasma cytokines and mRNA expression of immune genes in the intestine of broiler chickens.
Ghareeb K; Awad WA; Soodoi C; Sasgary S; Strasser A; Böhm J
PLoS One; 2013; 8(8):e71492. PubMed ID: 23977054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
